Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

New insights in the pathogenesis of multiple sclerosis-role of acrolein in neuronal and myelin damage.
Growth Hormone and Disease Severity in Early Stage of Multiple Sclerosis.
Structural correlates of subjective and objective memory performance in multiple sclerosis.
Neurophysiological Evidence of Compensatory Brain Mechanisms in Early-Stage Multiple Sclerosis.
Long-term results from a phase 2 extension study of fingolimod at high and approved dose in relapsing multiple sclerosis.
Prophylactic Effect of BIO-1211 Small-Molecule Antagonist of VLA-4 in the EAE Mouse Model of Multiple Sclerosis.
Targeting Central Nervous System B Cells in Progression of Multiple Sclerosis: Is Intrathecal Anti-CD20 a Therapeutic Option?
Use of Accelerometers to Measure Real-Life Physical Activity in Ambulatory Individuals with Multiple Sclerosis: A Pilot Study.
Cutting Edge: CD99 Is a Novel Therapeutic Target for Control of T Cell-Mediated Central Nervous System Autoimmune Disease.
The Incidence and Prevalence of Thyroid Disease Do Not Differ in the Multiple Sclerosis and General Populations: A Validation Study Using Administrative Data.
[Chemical constituents from roots of Illicium majus].
Treatment of mood disorders in multiple sclerosis.
Neuromyelitis optica spectrum disorders with multiple brainstem manifestations: a case report.
Iron accumulation in multiple sclerosis: an early pathogenic event.
White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI.
Alpha lipoic acid enhances endogenous peroxisome proliferator-activated receptor-γ to ameliorate experimental autoimmune encephalomyelitis.
Systematic Review and meta-analysis of the Efficacy of sphingosine-1-phosphate (S1P) receptor agonist FTY720 (fingolimod) in Animal Models of Stroke.
Bone health in chronic neurological diseases: a focus on multiple sclerosis and parkinsonian syndromes.
[The effect of genetic factors on the phenotypic expression of multiple sclerosis.]
Metallic gold beads in hyaluronic acid: a novel form of gold-based immunosuppression? Investigations of the immunosuppressive effects of metallic gold on cultured J774 macrophages and on neuronal gene expression in experimental autoimmune encephalomyeliti
NONINVASIVE ASSESSMENTS OF OPTIC NERVE NEURODEGENERATION IN TRANSGENIC MICE WITH ISOLATED OPTIC NEURITIS.
Protective effect of cytosolic phospholipase A2 inhibition against inflammation and degeneration by promoting regulatory T cells in rats with experimental autoimmune encephalomyelitis.
Impact of a 5-day expedition to machu picchu on persons with multiple sclerosis.
Gene therapy with Mitochondrial Heat Shock Protein 70 Suppresses Visual Loss and Optic Atrophy in Experimental Autoimmune Encephalomyelitis.
Treatment of neuromyelitis optica: state-of-the-art and emerging therapies.

Pages